Over the last few years, pharmaceutical companies have seen an increasing level of regulatory scrutiny and highly critical media coverage of the industry’s R&D, marketing and manufacturing practices. As a result, there has been a noticeable decline in consumer and investor confidence and a growing degree of negative perceptions about the industry.
This combination of factors has placed pharmaceutical companies under intense pressure to take actions that will restore their declining reputations and strengthen the public’s sense of trust in the industry.
This report, which is the first in a series of comprehensive reports, that explores the reputation issues and compliance challenges facing the industry. We believe the approach outlined in the report provides far-reaching benefits to pharmaceutical companies by enabling them to increase trust and enhance relationships with key stakeholders.
By considering and implementing a strategy around the effective management of stakeholder interests, including regulatory and compliance requirements, we are convinced that the industry will have a greater ability to define and direct its business on its own terms and continue to serve as a profitable and innovative contributor to the human condition.
Publications Search Page
